Zus Health raises $33 million Series B for its AI-native data platform, total funding tops $100 million.
funding healthcare
| Source: Techmeme | Original article
Zus Health, an AI‑native healthcare data platform, secured a $33 million Series B round led by Drive Capital, pushing its total funding past $100 million.
Zus Health, the startup developing an AI‑native platform for healthcare data, announced a $33 million Series B financing round led by Drive Capital. The new capital lifts the company’s total funding to more than $100 million, underscoring investor confidence in its vision of a unified, AI‑ready health data ecosystem.
The raise comes as the firm continues to build a platform that stitches together clinical, claims and genomic information into a single, interoperable repository. By embedding generative‑AI capabilities at the data layer, Zus Health aims to accelerate the creation of predictive models, decision‑support tools and personalized‑medicine applications that have traditionally been hampered by fragmented data silos. The involvement of Drive Capital, a venture firm with a track record in AI‑driven enterprises, signals that the market sees a clear commercial upside in turning raw health records into AI‑fuelled insights.
The funding will be used to expand the platform’s data ingestion pipelines, deepen partnerships with health systems and insurers, and scale the engineering team needed to meet stringent privacy and compliance standards. As the healthcare sector races to embed AI across diagnostics, drug discovery and care coordination, a robust, interoperable data foundation could become a decisive competitive edge.
Watch for Zus Health’s next product milestones, including any pilot deployments with major providers or integration with emerging AI models. Regulatory scrutiny around patient data use and the company’s ability to secure large‑scale, consented datasets will also shape its trajectory in the rapidly evolving AI‑health landscape.
Sources
Back to AIPULSEN